Skip to main content

FDA recall, , Moderate risk

Radnostix Sodium Iodide I-131 Oral Solution

Sodium Iodide (I-131) Solution contains particulate matter due to production issues.

What happened

Radnostix, located in Idaho Falls, Idaho, recalled Sodium Iodide (I-131) Solution, Therapeutic Oral, due to the presence of particulate matter caused by production issues. The product is packaged as 1 ml, 2 ml, and 3 ml V-vials, with specific NDC and order listings. The recall, which began on January 26, 2026, was added to the FDA's Enforcement Report on March 5, 2026, and classified on March 13, 2026. The product was distributed nationwide in the USA and Puerto Rico, with 16 units affected.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:

  1. Check the FDA or company notice for instructions specific to this product.
  2. Ask your pharmacist or doctor whether your lot is affected and what to do.

Is yours affected?

Match the list below, then check the codes the FDA notice also names.

An NDC (National Drug Code) is usually printed on the drug's label.

  1. Sodium Iodide (I-131) Solution, Therapeutic Oral

    NDC
    • 69208-003-15
    • 69208-003-25
    • 69208-003-35
    Lot code
    • I012626R-01

From the FDA notice

Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333, 49339, 49341,49355, 49364, 49380, 49392. (b) 2 ml V-Vial, NDC 69208-003-25; Order 49353,49457, 49477. (c) 3 ml V-vial, NDC 69208-003-35; Order 49454,49406.

Recall details

Company began the recall
Sold in

Nationwide in the USA and Puerto Rico

Company
RadnostixIdaho Falls, Idaho
Risk

Moderate risk

Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98470
Recall number
D-0389-2026
Quantity recalled
16 units

All recalls from Radnostix

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report

  3. In FDA's weekly enforcement report

  4. Classified by FDA

  5. Listed on Recall Canary

  6. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)